S-1: Elevai Labs Inc. Enters Distribution Agreement with Refine USA, LLC

Elevai Labs Inc. has established a non-exclusive authorized distributor agreement with Refine USA, LLC for its skincare products in the United States.

Summary

• Elevai Labs Inc. has entered into a non-exclusive Authorized Distributor Agreement with Refine USA, LLC, effective August 30, 2022.
• Refine USA, LLC is appointed as a non-exclusive authorized distributor of Elevai's skincare products in the United States.
• The agreement specifies limitations on the distributor, including restrictions on marketing and selling products outside the designated territory or on the internet without approval.
• Refine USA is responsible for maintaining an adequate supply of products, qualified personnel, and complying with Elevai's marketing guidelines.
• The pricing of products is confidential and subject to change with 60 days' notice.
• The initial term of the agreement is six months, with potential renewal based on performance and mutual agreement.
• The agreement outlines termination conditions, including breaches, insolvency, or failure to meet minimum purchase quantities.
• Distributor is responsible for obtaining necessary licenses and permits, as well as collecting and remitting applicable sales taxes.
• The agreement includes clauses on intellectual property, confidentiality, insurance, indemnification, and dispute resolution via arbitration.
• Distributor must maintain commercial general liability insurance with a limit of not less than $2,000,000 per occurrence.

Sentiment

Score: 7

Explanation: The document outlines a standard business agreement with clear terms and conditions, suggesting a neutral to positive outlook for both parties. The agreement's focus on sales targets and brand protection indicates a proactive approach to market expansion.

Positives

• The agreement allows Elevai Labs to expand its distribution network in the United States.
• Refine USA is obligated to use its best efforts to maximize sales of the Products.
• Distributor has the right to request that Company grant Distributor the exclusive right to distribute some or all of the Products in one or more of the states which comprise the Territory.

Negatives

• The agreement is non-exclusive, meaning Elevai can appoint other distributors in the same territory, some of which may be competitors of Refine USA.
• Distributor is restricted from marketing or selling products outside of the Territory, including to any person within the Territory that Distributor knows or should know will likely market, sell or distribute any Products outside of the Territory.
• Distributor is restricted from marketing, selling or distributing any Products on the internet (including without limitation, Amazon, eBay, Facebook or any other online marketplace or on any social media platform), with the sole exception of (i) Distributors website set forth on Exhibit A (if any) and (ii) any other website approved by Company in writing (each, an Approved Website).

Risks

• The agreement can be terminated if Refine USA fails to meet minimum purchase quantities or breaches the agreement.
• Elevai has the right to allocate production of Products among its own customers, Distributor, and Companys other distributors in its sole and reasonable discretion.
• The success of the distribution agreement depends on Refine USA's ability to effectively market and sell the products.
• The agreement is subject to potential disputes and legal proceedings, requiring resources for resolution.

Future Outlook

The agreement may be renewed for additional one-year terms if Refine USA meets performance criteria and both parties agree to the KPIs for the renewal term.

Industry Context

This agreement reflects a common strategy in the skincare industry where companies partner with distributors to expand their market reach and sales volume.

Comparison to Industry Standards

• The agreement's terms, such as non-exclusivity and sales targets, are typical in distribution agreements.
• The insurance requirements and intellectual property protection clauses are standard for protecting the brand and assets of Elevai Labs.
• The dispute resolution process through arbitration is a common method for resolving conflicts in commercial agreements.

Stakeholder Impact

• Shareholders: Potential for increased revenue and market share for Elevai Labs.
• Customers: Increased availability of Elevai products in the United States.
• Employees: Potential for increased sales and growth within Elevai Labs.

Next Steps

• Refine USA will begin marketing and selling Elevai's skincare products in the United States.
• Elevai Labs will monitor Refine USA's performance against the KPIs outlined in the agreement.
• The parties will meet quarterly to discuss performance and address any issues.
• The parties will negotiate and complete Exhibit C (KPIs) within thirty (30) days of the six (6) month anniversary of the Effective Date.

Key Dates

Keywords

distributor agreement, skincare products, authorized distributor, Refine USA, Elevai Labs, distribution, exosomes, sales, marketing, territory